Back to Journals » Drug Design, Development and Therapy » Volume 9

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

Total article views   HTML views PDF downloads Totals
11,441 Dovepress* 9,822+ 1,635 11,457
PubMed Central* 1,619 437 2,056
Totals 11,441 2,072 13,513
*Since 8 June 2015
+Since July 2016

View citations on PubMed Central and Google Scholar